Li, Chuanxing <br/><br/>
Feasibility of (125)I brachytherapy combined with sorafenib treatment in patients with multiple lung metastases after liver transplantation for hepatocellular carcinoma.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Nov 2010 
 - 1633-40 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-010-0821-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Benzenesulfonates--therapeutic use<br/>Brachytherapy--methods<br/>Carcinoma, Hepatocellular--surgery<br/>Cause of Death<br/>Combined Modality Therapy<br/>Follow-Up Studies<br/>Humans<br/>Iodine Radioisotopes--therapeutic use<br/>Liver Neoplasms--surgery<br/>Liver Transplantation<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Patient Care Planning<br/>Phenylurea Compounds<br/>Pyridines--therapeutic use<br/>Sorafenib<br/>Survival Rate<br/>Time Factors